News
Amgen said on Monday its experimental cancer therapy significantly improved overall survival in patients with advanced ...
9h
Medpage Today on MSNThis Dietary Pattern Is Linked With Lower Crohn's Disease RiskIn a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of ...
The (Raleigh) News & Observer on MSN20h
Future jet, big data center, more pharma: NC’s top 2025 jobs announcements (so far)Halfway through the year, these companies have pledged to hire the most workers in North Carolina. One is a record setter.
An addition to a Columbus factory is part of a planned $1B U.S. expansion for Central Ohio's second-largest manufacturer.
Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...
In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...
Amgen & Zai Lab's trial shows bemarituzumab + chemo boosts survival in gastric cancer with FGFR2b. Read more here.
Back in 2021, Amgen picked up the phase 3-ready candidate in a $1.9 billion acquisition of Five Prime Therapeutics. The ...
6h
AtoZ Sports on MSNDetroit Lions legend Barry Sanders has let a terrifying personal experience guide him to advocate for a very important causeDetroit Lions legend Barry Sanders has let a terrifying personal experience guide him to advocate for a very important cause ...
US biotech major Amgen today announced the Phase III FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus ...
THOUSAND OAKS, Calif., June 30, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met ...
Amgen said a Phase 3 trial of its gastric cancer treatment, bemarituzumab, met its primary endpoint of overall survival at a pre-specified interim analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results